2026. Targeted Nanostructured Lipid Carrier-Mediated Flavonoid Delivery for Enhanced Therapeutic Efficacy in Non-Small Cell Lung Cancer (NSCLC). Ayurveda, Pharmacy and Integrative Medical Research (APIMR). 1, 1 (Jun. 2026), 73–97.